| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/26/2005 | CN1569099A rheumatism treating Chinese medicinal paste |
| 01/26/2005 | CN1569098A Rheumatism treating Chinese medicinal paste |
| 01/26/2005 | CN1569088A 'Heiguteng' exract, its pharmaceutical composition and its use |
| 01/26/2005 | CN1569085A Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis |
| 01/26/2005 | CN1569074A Medicine for treating scapulohumeral periarthritis |
| 01/26/2005 | CN1569061A Medicine for treating traumatic injury and bone fracture |
| 01/26/2005 | CN1569057A Chinese traditional medicine for treating rheumatoid arthritis |
| 01/26/2005 | CN1569053A Chinese medicinal herb composition for treating rheumatism |
| 01/26/2005 | CN1569039A Powder for treating hyperosteogeny and protrusion of lumber and spondylopathy intervertebral disc and its preparation |
| 01/26/2005 | CN1569034A Bone strengthening Chinese medicinal preparation for treating osteoporosis and its preparing method |
| 01/26/2005 | CN1568965A Medicine for treating osteoporosis and its preparing method |
| 01/26/2005 | CN1568951A Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 01/26/2005 | CN1186352C HAb18G(/CD147) peptide agonist and its prepn and use |
| 01/26/2005 | CN1186336C Prepn and application in preparing medicine of fraxinus general coumarin |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186088C Tiegudan for ischemic necrosis of fernoral head and its preparation |
| 01/26/2005 | CN1186085C Traditional Chinese medicine for treating deformed soft-tissue |
| 01/26/2005 | CN1186084C Massage ointment for treating neck, shoulder, waist and leg pain, and extremity numbness |
| 01/26/2005 | CN1186067C Medicine for treating acute muscle and tendon injury and its preparation method |
| 01/26/2005 | CN1186058C Medicine for treating arthritis pain and its preparation method |
| 01/26/2005 | CN1186056C Medicine for treating osteoproliferation |
| 01/26/2005 | CN1186054C Medicine for treating osteoporosis and its preparation process |
| 01/26/2005 | CN1186050C Ointment for removing necrosis, promoting granulation and invigorating bone and its preparation |
| 01/26/2005 | CN1186045C Fracture-setting medicine |
| 01/26/2005 | CN1186043C Externally applied medicine for treating osteopathy and its preparation method |
| 01/26/2005 | CN1186039C Method for preparing Chinese medicine composition for treating ankylosing spondylitis complicated necrosis of femoral head |
| 01/26/2005 | CN1186013C Peroral medicine deliver controlled system providing temporal and spatial control |
| 01/25/2005 | US6846908 DCR-5 bone affecting ligand |
| 01/25/2005 | US6846907 Osteoporosis treatment |
| 01/25/2005 | US6846906 Modified proteins of the TGF-β superfamily, including morphogenic proteins |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846824 E.g., ethyl 3-(4-(2-(3-oxo-2H-1,4-benzoxazin-4-yl)ethoxy)-phenyl-2-ethoxypropenoate where 1,4-benzothiazine or quinoxaline can be substituted for the benzoxazine ring; anticholesterol, diabetic agents; obesity; hyperlimpidemia |
| 01/25/2005 | US6846818 Selective inhibitors of cyclooxygenase-2 |
| 01/25/2005 | US6846811 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer |
| 01/25/2005 | US6846499 Medical effect of jojoba oil |
| 01/25/2005 | US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/20/2005 | WO2005005606A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | WO2005005434A1 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 01/20/2005 | WO2005005433A1 Therapeutic agent for hyperpotassemia and bone disease |
| 01/20/2005 | WO2005005383A1 Amino alcohol compound |
| 01/20/2005 | WO2005005380A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | WO2004085448A3 Unsaturated phosphinyl-phosphonate phosphate transport inhibitors |
| 01/20/2005 | WO2004082608A3 Ligands for tgf-beta binding proteins and uses thereof |
| 01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
| 01/20/2005 | WO2003082302A9 Bioadhesive directed somatic cell therapy |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
| 01/20/2005 | US20050014817 Fluorothiophene derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/20/2005 | US20050014768 Antiinflammatory agents; analgesics |
| 01/20/2005 | US20050014735 Therapy for autoimmune disease; antiallergens; antihistamines |
| 01/20/2005 | US20050014731 Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014703 Cell differentiation, regeneration of epithelium pancreas cells into insulin producing beta-cells; administrering a peptidyl- peptidase activator |
| 01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |
| 01/20/2005 | US20050014229 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050014187 Novel polypeptide hormone phosphatonin |
| 01/20/2005 | US20050013874 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticles and therapeutic agent for treating zinc deficiency |
| 01/20/2005 | US20050013830 Containing cordyceps sinensis or extract; suppressing decrease of spongy bone density |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013814 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 01/20/2005 | DE10327719A1 VEGFR-2 und VEGFR-3 Inhibitorische Anthranylamidpyridone VEGFR-2 and VEGFR-3 inhibitory Anthranylamidpyridone |
| 01/20/2005 | DE102004014061A1 Amid-substituierte 1,2,4-Triazin-5(2H)-one Amide substituted 1,2,4-triazine-5 (2H) -ones |
| 01/20/2005 | CA2530182A1 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | CA2530025A1 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/19/2005 | EP1498133A1 Use of a pak inhibitor for the treatment of a joint disease |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1497656A2 Diagnosis of carcinoma using raig1 polypeptides |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1497296A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 01/19/2005 | EP1497294A1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 01/19/2005 | EP1497285A1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 01/19/2005 | EP1497280A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2 |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496995A1 Method and apparatus for ultrasound treatment of connective tissue |
| 01/19/2005 | EP1496941A1 Glycodendrimers having biological activity |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496914A1 (20S)-1a-HYDROXY-2a-METHYL AND 2&bgr;-METHYL-19-NOR-VITAM IN D sb 3 /sb AND THEIR USES |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496907A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496904A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496894A1 Angiogenesis inhibitors |